본문 바로가기
KERD
논문KCI 등재

돌발성 난청 환자에서 고혈압과 당뇨 유무에 따른 Lipo-Prostaglandin의 치료 효과 비교 연구

A Comparative Study on the Treatment Effect of Lipo-Prostagladin with Hypertension and Diabetes Mellitus in Sudden Sensorineural Hearing Loss Patients

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류이비인후과학

초록

Background and Objectives Several drugs which can improve blood flow have been usedas treatment options for sudden sensorineural hearing loss (SSNHL) based on the theory thatimprovement of perfusion into the inner ear will help restore hearing. Lipo-prostaglandin E1(lipo-PGE1) is a well-known vasodilator that increases peripheral blood flow. The purpose ofthis study was to investigate the effect of lipo-PGE1 on the recovery of the SSNHL patientswith hypertension or diabetes. Subjects and Method We retrospectively analyzed 801 patients who were diagnosed withSSNHL from January 2007 to December 2018. All patients were treated with 48 mg of methylprednisolonefor 5 days; some patients received lipo-PGE1, depending on the attending physician. They were divided into four groups according to the presence or absence of hypertensionand diabetes. Hearing test was performed again one month after treatment and comparedwith the test results at the time of diagnosis. Results As a result of comparing the hearing thresholds before and after the treatment ineach group, there was a significant improvement in hearing thresholds in all groups (p<0.001). However, when comparing the effect of lipo-PGE1 for hearing change, there was a significantdifference only in the group without any underlying diseases (p=0.016). Conclusion In this study, we show that lipo-PGE1 was helpful in hearing recovery whenused in patients without underlying diseases rather than patients with hypertension or diabetes. Further studies will be needed to determine the therapeutic effects of lipo-PGE1 as an adjuvanttreatment in SSNHL patients.

Abstract

Background and Objectives Several drugs which can improve blood flow have been usedas treatment options for sudden sensorineural hearing loss (SSNHL) based on the theory thatimprovement of perfusion into the inner ear will help restore hearing. Lipo-prostaglandin E1(lipo-PGE1) is a well-known vasodilator that increases peripheral blood flow. The purpose ofthis study was to investigate the effect of lipo-PGE1 on the recovery of the SSNHL patientswith hypertension or diabetes. Subjects and Method We retrospectively analyzed 801 patients who were diagnosed withSSNHL from January 2007 to December 2018. All patients were treated with 48 mg of methylprednisolonefor 5 days; some patients received lipo-PGE1, depending on the attending physician. They were divided into four groups according to the presence or absence of hypertensionand diabetes. Hearing test was performed again one month after treatment and comparedwith the test results at the time of diagnosis. Results As a result of comparing the hearing thresholds before and after the treatment ineach group, there was a significant improvement in hearing thresholds in all groups (p<0.001). However, when comparing the effect of lipo-PGE1 for hearing change, there was a significantdifference only in the group without any underlying diseases (p=0.016). Conclusion In this study, we show that lipo-PGE1 was helpful in hearing recovery whenused in patients without underlying diseases rather than patients with hypertension or diabetes. Further studies will be needed to determine the therapeutic effects of lipo-PGE1 as an adjuvanttreatment in SSNHL patients.

참고문헌 (24)

  1. Kuhn M, "Sudden sensorineural hearing loss: A review of diagnosis, treatment, and prognosis", Trends Amplif, 15(3), pp.91~105 (2011)
  2. Wilson WR, "The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study", Arch Otolaryngol, 106(12), pp.772~776 (1980)
  3. Ballesteros F, "Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors", Audiol Neurootol, 14(3), pp.139~145 (2009)
  4. 신동주, "소아 돌발성 난청의 임상적 특징과 결과", 대한이비인후-두경부외과학회지, 59(2), pp.104~109 (2016), 대한이비인후과학회[DOI]
  5. Rarey KE, "Correlative evidence of hypertension and altered cochlear microhomeostasis : Electrophysiological changes in the spontaneously hypertensive rat", Hear Res, 102(1-2), pp.63~69 (1996)
  6. de Moraes Marchiori LL, "Hypertension as a factor associated with hearing loss", Braz J Otorhinolaryngol, 72(4), pp.533~540 (2006)
  7. Rust KR, "Inner ear damage secondary to diabetes mellitus. II. Changes in aging SHR", N-cp rats, 1992, pp.118(4), 397~400
  8. Nagaoka J, "Idiopathic sudden sensorineural hearing loss: Evolution in the presence of hypertension, diabetes mellitus and dyslipidemias", Braz J Otorhinolaryngol, 76(3), pp.363~369 (2010)
  9. 임기정, "돌발성 난청", Hanyang Medical Reviews, 35(2), pp.92~96 (2015), 한양대학교 의과대학[DOI]
  10. Tooke JE, "The microcirculation in diabetes", Diabet Med, 4(3), pp.189~196 (1987)
  11. Makishima K, "Pathological changes of the inner ear and central auditory pathway in diabetics", Ann Otol Rhinol Laryngol, 80(2), pp.218~228 (1971)
  12. 김명구, "돌발성 난청 환자에서 Lipoprostaglandin E1 과 Carbogen 흡입의 병행치료 효과에 관한 연구", 대한이비인후-두경부외과학회지, 51(1), pp.22~27 (2008), 대한이비인후과학회
  13. Park SY, "The effect of combined antiviral agent therapy and stellate ganglion block for sudden sensorineural hearing loss and appropriate patients to evaluate the therapeutic effect", Korean J Otolaryngol-Head Neck Surg, 44(8), pp.817~821 (2001)
  14. Parnes LS, "Corticosteroid pharmacokinetics in the inner ear fluids : An animal study followed by clinical application", Laryngoscope, 109(7 Pt 2), pp.1~17 (1999)
  15. Eun SJ, "The efficacy of stellate ganglion block in the treatment of idiopathic sudden sensorineural hearing loss", Korean J Otolaryngol-Head Neck Surg, 34(1), pp.28~33 (1991)
  16. Ahn JH, "Therapeutic effect of lipoprostaglandin E1 on sudden hearing loss", Am J Otolaryngol, 26(4), pp.245~248 (2005)
  17. 안중호, "제2형 당뇨환자에서 발생한 돌발성 난청의 치료제로서 Lipo-Prostalandin E₁의 효능분석", 대한이비인후-두경부외과학회지, 49(10), pp.973~977 (2006), 대한이비인후과학회
  18. Murray KJ, "Cyclic AMP and mechanisms of vasodilation", Pharmacol Ther, 47(3), pp.329~345 (1990)
  19. Salganicoff L, "An hypothesis on the consolidation and PGE1-induced deconsolidation of a platelet plug", Platelets, 14(7-8), pp.463~471 (2003)
  20. Nishimura T, "Effects of intravenous administration of prostaglandin E(1)and lipo-prostaglandin E(1)on cochlear blood flow in guinea pigs", Eur Arch Otorhinolaryngol, 259(5), pp.253~256 (2002)
  21. Bachor E, "Vascular variations of the inner ear", Acta Otolaryngol, 121(1), pp.35~41 (2001)
  22. Fukui M, "Idiopathic sudden hearing loss in patients with type 2diabetes", Diabetes Res Clin Pract, 63(3), pp.205~211 (2004)
  23. Ogawa K, "Effect of prostaglandin E1on idiopathic sudden sensorineural hearing loss : A double-blinded clinical study", Otol Neurotol, 23(5), pp.665~668 (2002)
  24. Agarwal S, "Effects of hypertension on hearing", Indian J Otolaryngol Head Neck Surg, 65(Suppl 3), pp.614~618 (2013)

관련 논문AI추천

Comparative Analysis of the Combined Therapeutic Effects of Lipoprostaglandin E1 on Sudden Idiopathic Sensorineural Hearing Loss김명구, 김준수, 심행선대한청각학회 · Journal of Audiology & Otology2017 · 제21권 제1호돌발성 난청 환자에서 Lipoprostaglandin E1 과 Carbogen 흡입의 병행치료 효과에 관한 연구김명구대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2008 · 제51권 제1호돌발성 난청에서 스테로이드 초치료군과 재치료군의 성적 비교고재범, 권재환, 김창회, 이환호, 조기헌대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2019 · 제62권 제12호Comparison of Intratympanic, Systemic, and Combined Steroid Therapies for Sudden Sensorineural Hearing Loss in Patients with Diabetes Mellitus강현택, 김보경, 김효준, 이세아, 이윤지, 이종대대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2019 · 제62권 제7호심혈관계 위험요인이 돌발성 난청의 회복에 미치는 영향공성호, 박석원, 박주현, 유건희, 임윤성, 조창건, 최세인, 최용준대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2016 · 제59권 제7호돌발성 난청 환자에서 전신 스테로이드 단독요법과 고실 내 스테로이드 병용요법의 치료 효과 비교이현진, 임소연, 장경일, 전은주대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2021 · 제64권 제3호

이 간행물의 다른 논문 (7건)